SE9402528D0 - Hard tissue stimulant with electricity - Google Patents

Hard tissue stimulant with electricity

Info

Publication number
SE9402528D0
SE9402528D0 SE9402528A SE9402528A SE9402528D0 SE 9402528 D0 SE9402528 D0 SE 9402528D0 SE 9402528 A SE9402528 A SE 9402528A SE 9402528 A SE9402528 A SE 9402528A SE 9402528 D0 SE9402528 D0 SE 9402528D0
Authority
SE
Sweden
Prior art keywords
hard tissue
pct
electricity
sec
date
Prior art date
Application number
SE9402528A
Other languages
Swedish (sv)
Inventor
Hans-Arne Hansson
Ruden Gunilla Johansson
Olle Larm
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9402528A priority Critical patent/SE9402528D0/en
Publication of SE9402528D0 publication Critical patent/SE9402528D0/en
Priority to BR9508322A priority patent/BR9508322A/en
Priority to DE69527203T priority patent/DE69527203T2/en
Priority to CZ1997140A priority patent/CZ289981B6/en
Priority to KR1019970700338A priority patent/KR100395724B1/en
Priority to NZ290219A priority patent/NZ290219A/en
Priority to US08/505,353 priority patent/US5894070A/en
Priority to ES95926565T priority patent/ES2178675T3/en
Priority to RU97102352/14A priority patent/RU2153877C2/en
Priority to JP50495596A priority patent/JP3492377B2/en
Priority to DK95926565T priority patent/DK0771206T3/en
Priority to PL95318326A priority patent/PL181764B1/en
Priority to EP95926565A priority patent/EP0771206B1/en
Priority to FI970202A priority patent/FI970202A7/en
Priority to PCT/SE1995/000857 priority patent/WO1996002259A1/en
Priority to MX9700443A priority patent/MX9700443A/en
Priority to HU9700160A priority patent/HU220770B1/en
Priority to CA002194462A priority patent/CA2194462C/en
Priority to AU30895/95A priority patent/AU696183C/en
Priority to AT95926565T priority patent/ATE219678T1/en
Priority to CN95195024A priority patent/CN1081923C/en
Priority to IS4409A priority patent/IS1793B/en
Priority to NO19970215A priority patent/NO310223B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Saccharide Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PCT No. PCT/SE95/00857 Sec. 371 Date Aug. 30, 1995 Sec. 102(e) Date Aug. 30, 1995 PCT Filed Jul. 13, 1995 PCT Pub. No. WO96/02259 PCT Pub. Date Feb. 1, 1996The use of chitosan and a polysaccharide immobilized thereto selected from heparin, heparan sulphate, chondroitinsulphates and dextran sulphate for the manufacture of an agent capable of providing stimulated regeneration of hard tissue; a process for stimulating regeneration of hard tissue in connection with so called osseointegration; and implant intended for integration into hard tissue, particularly bone tissue.
SE9402528A 1994-07-19 1994-07-19 Hard tissue stimulant with electricity SE9402528D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (en) 1994-07-19 1994-07-19 Hard tissue stimulant with electricity
CN95195024A CN1081923C (en) 1994-07-19 1995-07-13 Use of chitosan and polysaccharides immobilized thereon for the production of hard tissue stimulants
DK95926565T DK0771206T3 (en) 1994-07-19 1995-07-13 Hard tissue stimulant
EP95926565A EP0771206B1 (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
CZ1997140A CZ289981B6 (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
KR1019970700338A KR100395724B1 (en) 1994-07-19 1995-07-13 Hard Tissue Stimulating Agent
NZ290219A NZ290219A (en) 1994-07-19 1995-07-13 Osseointegration implant and its use in regenerating hard tissue
US08/505,353 US5894070A (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
ES95926565T ES2178675T3 (en) 1994-07-19 1995-07-13 STIMULATING AGENT OF HARD FABRIC.
RU97102352/14A RU2153877C2 (en) 1994-07-19 1995-07-13 Agent stimulating regeneration of solid tissue
JP50495596A JP3492377B2 (en) 1994-07-19 1995-07-13 Hard tissue stimulant
BR9508322A BR9508322A (en) 1994-07-19 1995-07-13 Use of chitosan and an immobilized polysaccharide in the same process to stimulate and / or accelerate regeneration of rigid tissue and implant intended for integration into rigid tissue
PL95318326A PL181764B1 (en) 1994-07-19 1995-07-13 Coating of the implant for coating on the implant for insertion into hard tissue PL PL PL
DE69527203T DE69527203T2 (en) 1994-07-19 1995-07-13 ACTIVE SUBSTANCE FOR STIMULATING HARD TISSUE
FI970202A FI970202A7 (en) 1994-07-19 1995-07-13 Hard tissue stimulant
PCT/SE1995/000857 WO1996002259A1 (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
MX9700443A MX9700443A (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent.
HU9700160A HU220770B1 (en) 1994-07-19 1995-07-13 The use of a polysaccharide fixed to chitosan for the preparation of a composition for stimulating hard tissue regeneration
CA002194462A CA2194462C (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
AU30895/95A AU696183C (en) 1994-07-19 1995-07-13 Hard tissue stimulating agent
AT95926565T ATE219678T1 (en) 1994-07-19 1995-07-13 ACTIVE SUBSTANCE FOR STIMULATION OF HARD TISSUE
IS4409A IS1793B (en) 1994-07-19 1997-01-06 Use of chitosan and polysaccharide in conjunction with hard tissue regeneration, including transplantation
NO19970215A NO310223B1 (en) 1994-07-19 1997-01-17 Use of chitosan and a polysaccharide in connection with regeneration of hard tissue, as well as implant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9402528A SE9402528D0 (en) 1994-07-19 1994-07-19 Hard tissue stimulant with electricity

Publications (1)

Publication Number Publication Date
SE9402528D0 true SE9402528D0 (en) 1994-07-19

Family

ID=20394768

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9402528A SE9402528D0 (en) 1994-07-19 1994-07-19 Hard tissue stimulant with electricity

Country Status (22)

Country Link
US (1) US5894070A (en)
EP (1) EP0771206B1 (en)
JP (1) JP3492377B2 (en)
KR (1) KR100395724B1 (en)
CN (1) CN1081923C (en)
AT (1) ATE219678T1 (en)
BR (1) BR9508322A (en)
CA (1) CA2194462C (en)
CZ (1) CZ289981B6 (en)
DE (1) DE69527203T2 (en)
DK (1) DK0771206T3 (en)
ES (1) ES2178675T3 (en)
FI (1) FI970202A7 (en)
HU (1) HU220770B1 (en)
IS (1) IS1793B (en)
MX (1) MX9700443A (en)
NO (1) NO310223B1 (en)
NZ (1) NZ290219A (en)
PL (1) PL181764B1 (en)
RU (1) RU2153877C2 (en)
SE (1) SE9402528D0 (en)
WO (1) WO1996002259A1 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402528D0 (en) * 1994-07-19 1994-07-19 Astra Ab Hard tissue stimulant with electricity
KR100237738B1 (en) * 1997-04-26 2000-01-15 이용찬 Implant
DE19724869C2 (en) * 1997-06-12 1999-05-12 Henkel Kgaa Use of citosan derivatives for surface coating
EP0899247B1 (en) * 1997-08-28 2002-11-06 Ngk Spark Plug Co., Ltd Calcium phosphate cement and calcium phosphate cement composition
JP4215884B2 (en) * 1998-03-23 2009-01-28 日本特殊陶業株式会社 Calcium phosphate cement and calcium phosphate cement composition
US20030147860A1 (en) * 2002-02-07 2003-08-07 Marchosky J. Alexander Compositions and methods for forming and strengthening bone
EP1089785A1 (en) 1998-06-22 2001-04-11 Neovasys, Inc. Method, implant and delivery system for enhancing blood flow in tissue
ATE393171T1 (en) * 1998-11-10 2008-05-15 Netech Inc FUNCTIONAL CHITOSAND DERIVATIVES
FR2791262B1 (en) * 1999-03-22 2001-09-28 Virbac Sa COMPOSITIONS BASED ON CHONDROITINE AND CHITOSAN FOR THE PROTECTION, TREATMENT OR REPLACEMENT OF CONNECTIVE TISSUES
AU782394B2 (en) 1999-06-29 2005-07-21 J. Alexander Marchosky Compositions and methods for forming and strengthening bone
GB9920393D0 (en) * 1999-08-27 1999-11-03 Medix Scient Uk Limited Plant extract mixtures and their uses
FI19991852A7 (en) 1999-09-01 2001-03-02 Yli Urpo Antti Novel multilayer material comprising an active ingredient and its preparation
WO2001036000A1 (en) * 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
AU1848601A (en) * 1999-12-09 2001-06-18 Bio Syntech Canada Inc Mineral-polymer hybrid composition
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
JP5089006B2 (en) * 2000-06-29 2012-12-05 ピラマル ヘルスケア （カナダ） リミテッド Compositions and methods for repair and regeneration of cartilage and other tissues
ES2169681B1 (en) * 2000-08-10 2003-10-01 Osfarma S L PRODUCTION METHOD OF QUITOSAN FILMS WITH A HIGH CAPACITY OF CELLULAR ADHERENCE, OBRENIDO PRODUCT AND APPLICATIONS.
DE60125973D1 (en) * 2000-11-15 2007-02-22 Biosyntech Canada Inc METHOD FOR RECOVERING A DAMAGED BAND DISC
RU2212243C2 (en) * 2001-06-15 2003-09-20 Щиголева Светлана Александровна Preparation "cxa" for treatment of dermal diseases
ES2353116T3 (en) * 2002-07-16 2011-02-25 Bio Syntech Canada Inc. COMPOSITIONS FOR CYCLOMPATIBLE, INJECTABLE, SELF-GRINDING QUITOSANE DISSOLUTIONS TO ENCAPSULATE AND ADMINISTER LIVING CELLS OR BIOLOGICALLY ACTIVE FACTORS.
US20040054414A1 (en) 2002-09-18 2004-03-18 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
FR2844717B1 (en) * 2002-09-23 2006-07-07 Richard Cancel REINFORCING PLATE COMPRISING IN PARTICULAR CHITOSAN
RU2294751C2 (en) * 2002-09-30 2007-03-10 Реджен Байотек, Инк. Composition for stimulation formation of osseous tissue and bone joining
CN100394989C (en) * 2002-11-15 2008-06-18 华沙整形外科股份有限公司 Pharmaceutical use of a composition comprising particulate collagen-based material and synovial joint comprising said composition
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
DE10338110A1 (en) * 2003-08-15 2005-03-10 Biomet Deutschland Gmbh Chitosan-coated metallic article and method of making the same
CA2535169A1 (en) 2003-12-31 2005-07-21 Osteotech, Inc. Improved bone matrix compositions and methods
US8734525B2 (en) * 2003-12-31 2014-05-27 Warsaw Orthopedic, Inc. Osteoinductive demineralized cancellous bone
US20070231788A1 (en) * 2003-12-31 2007-10-04 Keyvan Behnam Method for In Vitro Assay of Demineralized Bone Matrix
FR2866571B1 (en) * 2004-02-20 2007-09-21 Philippe Zanchetta USE OF A MIXTURE OF SPECIFIC POLYSACCHARIDES AS INDICATED BY THE EZBONE INVENTOR COMPRISING HYALURONIC ACID, CHONDROID SULFATE, DERMATANE SULFATE AND HEPARIN IN BONE HEALING.
CA2565913A1 (en) * 2004-05-07 2005-11-17 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
AU2005239977B2 (en) * 2004-05-07 2010-11-11 The University Of Queensland Composition for stimulating bone growth and differentiation and method for isolating same
AU2005273077B2 (en) 2004-08-16 2011-02-24 Cellresearch Corporation Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
EP1838335A1 (en) * 2005-01-19 2007-10-03 Bonoss Medical AB Growth factor composition
EP1937326B1 (en) 2005-10-21 2018-09-12 CellResearch Corporation Pte Ltd Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom
AU2006308534B2 (en) * 2005-11-01 2013-02-07 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
US20090149421A1 (en) * 2005-11-04 2009-06-11 Bio Syntech Canada Inc. Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state
DE102006020035A1 (en) * 2006-04-26 2007-10-31 B. Braun Melsungen Ag Preparation and use of poly (hydroxyethyl starch) chitin and poly (carboxymethyl starch) chitin compounds
US8118779B2 (en) * 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US8399619B2 (en) * 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
EP1977739A1 (en) * 2007-04-03 2008-10-08 Bioiberica, S.A. Nanoparticulate composition of chitosan and chondroitin sulfate
CA3062443C (en) * 2007-06-15 2022-03-15 Warsaw Orthopedic, Inc. Method of treating tissue
EP2167147B1 (en) 2007-06-15 2017-03-29 Warsaw Orthopedic, Inc. Bone matrix compositions and methods
US9554920B2 (en) 2007-06-15 2017-01-31 Warsaw Orthopedic, Inc. Bone matrix compositions having nanoscale textured surfaces
US20110054408A1 (en) * 2007-07-10 2011-03-03 Guobao Wei Delivery systems, devices, tools, and methods of use
US9358113B2 (en) 2007-07-10 2016-06-07 Warsaw Orthopedic, Inc. Delivery system
ES2446544T3 (en) * 2007-10-19 2014-03-10 Warsaw Orthopedic, Inc. Demineralized bone matrix compositions and methods
GB2463474B (en) * 2008-09-11 2012-05-02 Agency Science Tech & Res Therapeutic bone growth and regeneration
RU2383564C1 (en) * 2008-11-21 2010-03-10 Астемир Икрамович Шайхалиев Composition - osteoinducer and osteoconductor in treatment of bone pathology in dentistry and oral surgery and method of obtaining composition - osteoinducer and osteoconductor in treatment of bone pathology in dentistry and oral surgery
US9220598B2 (en) * 2009-02-12 2015-12-29 Warsaw Orthopedic, Inc. Delivery systems, tools, and methods of use
EP2806896B1 (en) 2012-01-27 2018-01-03 F. Hoffmann-La Roche AG Chitosan covalently linked with small molecule integrin antagonist for targeted delivery
CN108610437A (en) * 2013-03-14 2018-10-02 金珂生物医疗公司 Bio-compatible and biological absorbable derivative chitosan composite
CN105126165B (en) * 2015-01-21 2017-12-08 中国人民解放军第三〇七医院 A kind of titanium dental implant material and preparation method and application

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL163522B (en) * 1970-07-20 1980-04-15 Montedison Spa PROCESS FOR PREPARING A CATALYST FOR THE POLYMERIZATION OF OLEFINS-1.
US4326532A (en) * 1980-10-06 1982-04-27 Minnesota Mining And Manufacturing Company Antithrombogenic articles
SE8200751L (en) * 1982-02-09 1983-08-10 Olle Larm PROCEDURE FOR COVALENT COUPLING FOR MANUFACTURE OF CONJUGATE AND REQUIRED PRODUCTS
JPS61253065A (en) * 1985-05-02 1986-11-10 片倉チツカリン株式会社 Medical composite material of chitosan derivative and collagen and its production
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5256447A (en) * 1991-12-31 1993-10-26 Minnesota Mining And Manufacturing Company Adhesive composition and method
CA2117347A1 (en) * 1991-12-31 1993-07-08 Joel D. Oxman Metal filled adhesive composition and method
SE9402528D0 (en) * 1994-07-19 1994-07-19 Astra Ab Hard tissue stimulant with electricity

Also Published As

Publication number Publication date
HU9700160D0 (en) 1997-03-28
ES2178675T3 (en) 2003-01-01
CA2194462A1 (en) 1996-02-01
HUT77607A (en) 1998-06-29
DK0771206T3 (en) 2002-08-19
EP0771206A1 (en) 1997-05-07
CN1157568A (en) 1997-08-20
CN1081923C (en) 2002-04-03
KR100395724B1 (en) 2004-02-18
ATE219678T1 (en) 2002-07-15
BR9508322A (en) 1998-01-06
HU220770B1 (en) 2002-05-28
WO1996002259A1 (en) 1996-02-01
FI970202A0 (en) 1997-01-17
NO970215D0 (en) 1997-01-17
IS4409A (en) 1997-01-06
AU3089595A (en) 1996-02-16
PL181764B1 (en) 2001-09-28
US5894070A (en) 1999-04-13
DE69527203T2 (en) 2003-01-09
EP0771206B1 (en) 2002-06-26
NO970215L (en) 1997-01-17
FI970202L (en) 1997-01-17
NO310223B1 (en) 2001-06-11
CA2194462C (en) 2007-07-10
CZ14097A3 (en) 1997-07-16
JP3492377B2 (en) 2004-02-03
IS1793B (en) 2001-12-12
NZ290219A (en) 1998-06-26
RU2153877C2 (en) 2000-08-10
PL318326A1 (en) 1997-06-09
JPH10502664A (en) 1998-03-10
FI970202A7 (en) 1997-01-17
AU696183B2 (en) 1998-09-03
DE69527203D1 (en) 2002-08-01
CZ289981B6 (en) 2002-05-15
MX9700443A (en) 1997-04-30
KR970704459A (en) 1997-09-06

Similar Documents

Publication Publication Date Title
SE9402528D0 (en) Hard tissue stimulant with electricity
NO952131D0 (en) Method of treating a surgical metal implant
RU97102352A (en) AGENT STIMULATING SOLID FABRIC
WO2003103527A3 (en) Natural implant system
ATE305276T1 (en) IMMEDIATE ORTHOPEDIC BONE SUPPORT IMPLANT
ATE279163T1 (en) TISSUE CELLULARIZATION
DE69524944D1 (en) METHOD FOR PRODUCING A DENTAL PRODUCT
SE9404196D0 (en) New antithrombotic formulation
ATE226439T1 (en) ANTI-ADHESIVE AGENTS
ATE90001T1 (en) PERCUTANEOUS IMPLANT.
BG102375A (en) Inoculation biocompatible hydrophilic gel, method for its preparation and application
DE59902305D1 (en) BIOACTIVE IMPLANTS AND METHOD FOR THE PRODUCTION THEREOF
DE69734349D1 (en) TREATMENT OF BONE DRESS WITH ADRENOMEDULLIN
MX9504896A (en) Bovine pericardium treated with glutaraldehyde, as thoracoabdominal wall, pulmonary and bronchial tissue bioprosthesis.
UA23896A (en) Method for treating fractures of mandible with slow consolidation